USA – AstraZeneca has announced that it will use Scorpion Therapeutics’ discovery platform to develop precision medicines against previously difficult-to-target cancer proteins. According to Susan Galbraith, AstraZeneca’s executive vice president…
Read More
USA – BenevolentAI, a leading clinical-stage AI drug discovery company, has expanded its AI-driven drug discovery collaboration with AstraZeneca, doubling the number of disease areas under investigation. The three-year extension…
Read More
USA – A group of institutional investors is urging companies to tie CEO pay to equitable access to the COVID vaccine. Pay packages for CEOs at COVID vaccine makers Pfizer,…
Read More
UNITED KINGDOM – The Food and Drug Administration (FDA) has approved Evusheld for the pre-exposure prophylaxis of COVID-19 in certain individuals 12 years of age and older weighing at least…
Read More
UNITED KINGDOM – AstraZeneca has announced that it would pay Ionis Pharmaceuticals, the market leader in RNA-targeted therapies, US$200 million for the rights to its investigational medicine, eplontersen. Eplontersen is…
Read More
BELGIUM – Novartis is putting US$150 million into a Parkinson’s disease drug candidate that is competing with drugs in development at companies such as Roche and AstraZeneca. Novartis will pay…
Read More
USA – Blueprint Medicines, a US-based biotech that specializes in targeted cancer drugs, is set to pay US$250 million in cash and another US$215 million in potential milestone payments to…
Read More
UNITED KINGDOM – Emergex Vaccines Holding Limited, a company tackling major global infectious disease threats by developing 100% synthetic T-Cell priming vaccines, has confirmed that its vaccine candidate for SARS-CoV-2,…
Read More
USA – The world’s major Covid-19 vaccine manufacturers have announced that they are working quickly to investigate and adapt their vaccines to a new and highly mutated strain of the…
Read More
UNITED KINGDOM – AstraZeneca, a global, science-led biopharmaceutical company has opened a billion-pound research center near the University of Cambridge hoping to build on the work in developing one of…
Read More